A detailed history of Northeast Financial Consultants Inc transactions in Dyadic International Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 250,000 shares of DYAI stock, worth $262,500. This represents 0.02% of its overall portfolio holdings.

Number of Shares
250,000
Previous 250,000 -0.0%
Holding current value
$262,500
Previous $417,000 11.27%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

BUY
$3.15 - $6.95 $787,500 - $1.74 Million
250,000 New
250,000 $1.57 Million

Others Institutions Holding DYAI

About DYADIC INTERNATIONAL INC


  • Ticker DYAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,423,100
  • Market Cap $29.8M
  • Description
  • Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...
More about DYAI
Track This Portfolio

Track Northeast Financial Consultants Inc Portfolio

Follow Northeast Financial Consultants Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

News

Stay updated on Northeast Financial Consultants Inc with notifications on news.